BioSpace News Archive

Drug Development

Ellipses Pharma Presents Preliminary Data From the First in Human Phase-1/2 Trial of EP0042, a Dual FLT-3 and Aurora Kinase Inhibitor, at ASH

Ellipses Pharma Limited has presented preliminary data from the first in human phase 1/2 trial of EP0042, a dual FLT-3 an Aurora kinase inhibitor, in patients with acute myeloid leukaemia at the 64th American Society of Hematology Annual Meeting in New Orleans, Louisiana.

December 12, 2022
·
4 min read
JW Therapeutics Presents Latest Clinical Data on Carteyva® in Follicular Lymphoma and Mantle Cell Lymphoma at the 64th ASH Annual Meeting

JW Therapeutics presented the latest clinical data on Carteyva® in Chinese adults with relapsed/refractory follicular lymphoma and relapsed/refractory mantle cell lymphoma at the 64th American Society of Hematology Annual Meeting.

December 12, 2022
·
4 min read
Deals

AMGEN TO HOST WEBCAST INVESTOR CALL FOLLOWING ANNOUNCED ACQUISITION OF HORIZON THERAPEUTICS

Amgen (NASDAQ:AMGN) will host a webcast call for the investment community following the announced acquisition of Horizon Therapeutics at 8:00 a.m. ET on Monday, December 12, 2022.

December 12, 2022
·
2 min read
Deals

VI Labs Acquires Motus Consumer Insights

Vi Labs, the market-leading Enterprise-AI for digital health, has acquired member acquisition analytics, site selection, and marketing BI company, Motus Consumer Insights.

December 12, 2022
·
3 min read
BioCapital

USP Launches R&D Analytical Solutions To Advance Continuous Manufacturing Technologies

The U.S. Pharmacopeia announced the opening of the USP Advanced Manufacturing Technology Lab in Richmond, Virginia as part of its launch of a suite of R&D analytical solutions.

December 12, 2022
·
5 min read
Business

Nuheara Expands US Retail Footprint With InnerScope Strategic Partnership

Nuheara Limited is pleased to announce a major expansion of its US retail footprint, from circa 300 points of sale currently to circa 4,600 over the coming months, with US FDA cleared self-fit hearing aids now being manufactured to fulfill initial orders from Best Buy and other US retail customers.

December 12, 2022
·
5 min read
TC BioPharm Reports First Half 2022 Financial Results and Provides Shareholder Update

TC BioPharm today announced its financial results for the first half ended June 30, 2022 and provided a shareholder update.

December 12, 2022
·
7 min read
BioMidwest

Functional precision oncology leader Kiyatec announces Series C round with US$18 million closing to accelerate adoption of transformational cancer platform

Kiyatec Inc. announced a closing of its Series C funding round totaling US$18 million from new and existing investors.

December 12, 2022
·
3 min read
Biotech Bay

Biotricity Files FDA 510(k) for a new Form Factor of its Biotres Cardiac Monitoring Device to Expand its Revenue Growth

Biotricity, Inc. today announced that it made a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a new form factor of its Biotres Cardiac Monitoring Device, a three lead device for ECG and arrhythmia monitoring that is intended for lower risk patients.

December 12, 2022
·
5 min read
Biotech Bay

AVITA Medical Submits FDA PMA Supplement to Further Expand Indication to Soft Tissue Repair

AVITA Medical, Inc. announced today the submission of a Premarket Approval (PMA) supplement application to the U.S. Food and Drug Administration (FDA) for the company’s RECELL ® System.

December 12, 2022
·
4 min read